Geopolitics Alpha

8-K - Prelude Therapeutics Inc (0001678660) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Prelude Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: PRLD, XLV, LLY, JNJ, ABBV
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Prelude Therapeutics Inc(0001678660) (Filer)PRLDGEOPOLITICS ALPHA

8-K - Prelude Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • PRLD Prelude Therapeutics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Prelude Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
PRLD+8.99%+9.86%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
ABBV-0.57%-0.04%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close
ABT+1.85%+0.80%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001193125-26-462029 Size: 21 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Prelude Therapeutics (PRLD) since this story, compared with the market

CompanyWhenMoveStatus
AbbVie (ABBV)three days earlier-0.04%final price
AbbVie (ABBV)five days earlier-0.57%final price
Abbott Laboratories (ABT)three days earlier+0.80%final price
Abbott Laboratories (ABT)five days earlier+1.85%final price
Johnson & Johnson (JNJ)three days earlier-1.97%final price
Johnson & Johnson (JNJ)five days earlier-1.35%final price
Eli Lilly (LLY)three days earlier-0.49%final price
Eli Lilly (LLY)five days earlier-2.25%final price
Merck (MRK)three days earlier-0.38%final price
Merck (MRK)five days earlier+0.65%final price
Prelude Therapeutics (PRLD)three days earlier+9.86%final price
Prelude Therapeutics (PRLD)five days earlier+8.99%final price
Select Sector Spdr Tr (XLV)three days earlier+0.04%final price
Select Sector Spdr Tr (XLV)five days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Prelude Therapeutics (PRLD)

Companies mentioned with this story

  • PRLD Prelude Therapeutics

    Prelude Therapeutics (PRLD) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Prelude Therapeutics Inc (0001678660) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> PRLD

  • XLV Select Sector Spdr Tr

    In “8-K - Prelude Therapeutics Inc (0001678660) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Prelude Therapeutics belongs to, so it often moves with news about it

  • LLY Eli Lilly

    For “8-K - Prelude Therapeutics Inc (0001678660) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • JNJ Johnson & Johnson

    In “8-K - Prelude Therapeutics Inc (0001678660) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • ABBV AbbVie

    AbbVie (ABBV) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Prelude Therapeutics Inc (0001678660) (Filer).” Reason on file: AbbVie is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • MRK Merck

    In “8-K - Prelude Therapeutics Inc (0001678660) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news

  • ABT Abbott Laboratories

    Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Prelude Therapeutics Inc (0001678660) (Filer).” Reason on file: Abbott Laboratories is a peer of Prelude Therapeutics in pharmaceutical preparations; rivals often move on the same news

How “8-K - Prelude Therapeutics Inc (0001678660) (Filer)” reaches Prelude Therapeutics (PRLD)

“8-K - Prelude Therapeutics Inc (0001678660) (Filer)” (16 Nov 2026) reaches Prelude Therapeutics (PRLD) through this story.

The link for Prelude Therapeutics (PRLD) is this: SEC 8-K filing -> direct issuer disclosure -> PRLD

Select Sector Spdr Tr (XLV) is here too. Its reason reads: Health Care Select Sector SPDR holds the health sector that Prelude Therapeutics belongs to, so it often moves with news about it

Price levels for Prelude Therapeutics (PRLD)

LLY traded between 1239.21 and 1458.90 across 20 sessions. The latest close on file is 1430.09.

What the saved facts support for Prelude Therapeutics (PRLD)

46 out of 100

“8-K - Prelude Therapeutics Inc (0001678660) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.